Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effects of Specialty and Co-Morbidity on Length of Stay in Ischemic Stroke and TIA
Cerebrovascular Disease and Interventional Neurology
(-)
044
Authors/Disclosures
Ramesh Madhavan, MD, FÂé¶¹´«Ã½Ó³»­ (International Medical Clinic) Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
John P. Sullivan, MD (Florida Neurology Group) No disclosure on file
Renee D. Van Stavern, MD, FÂé¶¹´«Ã½Ó³»­ (Washington University Dept of Neurology) An immediate family member of Dr. Van Stavern has received intellectual property interests from a publication relating to health care.
Kaiz S. Asif, MD (Ascension Health) Dr. Asif has nothing to disclose.
Stephen Martino, MD No disclosure on file
Thirukan R. Swaminathan, MBBS, PhD, FÂé¶¹´«Ã½Ó³»­ (Neuro Team One) Dr. Swaminathan has nothing to disclose.
No disclosure on file
No disclosure on file
Kumar Rajamani, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Rajamani has nothing to disclose.
Sunitha Santhakumar, MD No disclosure on file
Andrew Xavier, MD (Neuro Team One) No disclosure on file
Seemant Chaturvedi, MD, FAHA, FÂé¶¹´«Ã½Ó³»­ (University of Maryland) Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.